Overview

Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
Evaluating the use of Liraglutide in patients with Type 1 Diabetes.
Details
Lead Sponsor:
Kaleida Health
University at Buffalo
Collaborator:
University at Buffalo
Treatments:
Liraglutide